Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Total Non-Current Liabilities (2023 - 2025)

Historic Total Non-Current Liabilities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $273.9 million.

  • Nuvation Bio's Total Non-Current Liabilities rose 30310.93% to $273.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.9 million, marking a year-over-year increase of 30310.93%. This contributed to the annual value of $74.8 million for FY2024, which is 36714.35% up from last year.
  • Per Nuvation Bio's latest filing, its Total Non-Current Liabilities stood at $273.9 million for Q3 2025, which was up 30310.93% from $272.0 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Total Non-Current Liabilities peaked at $273.9 million during Q3 2025, and registered a low of $15.3 million during Q1 2023.
  • For the 3-year period, Nuvation Bio's Total Non-Current Liabilities averaged around $82.1 million, with its median value being $61.2 million (2024).
  • The largest annual percentage gain for Nuvation Bio's Total Non-Current Liabilities in the last 5 years was 36714.35% (2024), contrasted with its biggest fall of 1304.49% (2024).
  • Over the past 3 years, Nuvation Bio's Total Non-Current Liabilities (Quarter) stood at $16.0 million in 2023, then soared by 367.14% to $74.8 million in 2024, then surged by 266.3% to $273.9 million in 2025.
  • Its last three reported values are $273.9 million in Q3 2025, $272.0 million for Q2 2025, and $70.2 million during Q1 2025.